1887

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) replication and transcription activator (RTA) is well established as a key transcriptional activator that regulates the KSHV life cycle from latency to lytic replication. It is expressed immediately after infection and activates a number of viral genes leading to virus replication. The RTA-responsive element (RRE) in the RTA target gene promoters is critical for RTA to mediate this transactivation. A number of non-conserved RREs have been identified in various RTA-responsive promoters, and AT-rich sequences have been proposed to serve as RTA targets, but no consensus RRE sequence has been identified so far. Two non-conserved RREs (RRE1 and RRE2) containing AT-rich sequences have been identified previously in the promoter of one of the KSHV lytic genes, ORF57, which can be strongly activated by RTA. Based on homology with the consensus sequence of the Epstein–Barr virus Rta RRE, this study identified a third RTA-responsive element (RRE3) in the ORF57 promoter. This RRE comprised a GC-rich sequence that could bind RTA both and , and plays a role in RTA-mediated transactivation of the ORF57 promoter. The presence of two of the three RREs in close proximity to each other was required for optimal RTA-mediated transactivation of the ORF57 promoter, even though the presence of only one RRE is needed for RTA binding. These results suggest that the ability of RTA to mediate transcriptional activation is distinct from its ability to bind to its target elements.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.2008.006817-0
2009-04-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/90/4/944.html?itemId=/content/journal/jgv/10.1099/vir.2008.006817-0&mimeType=html&fmt=ahah

References

  1. Bowser B. S., Morris S., Song M. J., Sun R., Damania B. 2006; Characterization of Kaposi's sarcoma-associated herpesvirus (KSHV) K1 promoter activation by Rta. Virology 348:309–327 [CrossRef]
    [Google Scholar]
  2. Bu W., Carroll K. D., Palmeri D., Lukac D. M. 2007; Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta lytic switch protein functions as a tetramer. J Virol 81:5788–5806 [CrossRef]
    [Google Scholar]
  3. Carroll K. D., Bu W., Palmeri D., Spadavecchia S., Lynch S. J., Marras S. A., Tyagi S., Lukac D. M. 2006; Kaposi's sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway. J Virol 80:9697–9709 [CrossRef]
    [Google Scholar]
  4. Cesarman E., Chang Y., Moore P. S., Said J. W., Knowles D. M. 1995a; Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186–1191 [CrossRef]
    [Google Scholar]
  5. Cesarman E., Moore P. S., Rao P. H., Inghirami G., Knowles D. M., Chang Y. 1995b; In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86:2708–2714
    [Google Scholar]
  6. Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S. 1994; Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865–1869 [CrossRef]
    [Google Scholar]
  7. Chang P. J., Shedd D., Gradoville L., Cho M. S., Chen L. W., Chang J., Miller G. 2002; Open reading frame 50 protein of Kaposi's sarcoma-associated herpesvirus directly activates the viral PAN and K12 genes by binding to related response elements. J Virol 76:3168–3178 [CrossRef]
    [Google Scholar]
  8. Chang P. J., Shedd D., Miller G. 2005; Two subclasses of Kaposi's sarcoma-associated herpesvirus lytic cycle promoters distinguished by open reading frame 50 mutant proteins that are deficient in binding to DNA. J Virol 79:8750–8763 [CrossRef]
    [Google Scholar]
  9. Chen J., Ueda K., Sakakibara S., Okuno T., Yamanishi K. 2000; Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene. J Virol 74:8623–8634 [CrossRef]
    [Google Scholar]
  10. Chen L. W., Chang P. J., Delecluse H. J., Miller G. 2005; Marked variation in response of consensus binding elements for the Rta protein of Epstein–Barr virus. J Virol 79:9635–9650 [CrossRef]
    [Google Scholar]
  11. Deng H., Young A., Sun R. 2000; Auto-activation of the rta gene of human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus. J Gen Virol 81:3043–3048
    [Google Scholar]
  12. Deng H., Song M. J., Chu J. T., Sun R. 2002; Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus. J Virol 76:8252–8264 [CrossRef]
    [Google Scholar]
  13. Duan W., Wang S., Liu S., Wood C. 2001; Characterization of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 ORF57 promoter. Arch Virol 146:403–413 [CrossRef]
    [Google Scholar]
  14. Friborg J. Jr, Kong W., Hottiger M. O., Nabel G. J. 1999; p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402:889–894
    [Google Scholar]
  15. Gradoville L., Gerlach J., Grogan E., Shedd D., Nikiforow S., Metroka C., Miller G. 2000; Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line. J Virol 74:6207–6212 [CrossRef]
    [Google Scholar]
  16. Gruffat H., Sergeant A. 1994; Characterization of the DNA-binding site repertoire for the Epstein–Barr virus transcription factor R. Nucleic Acids Res 22:1172–1178 [CrossRef]
    [Google Scholar]
  17. Liang Y., Ganem D. 2004; RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA. J Virol 78:6818–6826 [CrossRef]
    [Google Scholar]
  18. Liang Y., Chang J., Lynch S. J., Lukac D. M., Ganem D. 2002; The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-J κ (CSL), the target of the Notch signaling pathway. Genes Dev 16:1977–1989 [CrossRef]
    [Google Scholar]
  19. Liao W., Tang Y., Kuo Y. L., Liu B. Y., Xu C. J., Giam C. Z. 2003; Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 transcriptional activator Rta is an oligomeric DNA-binding protein that interacts with tandem arrays of phased A/T-trinucleotide motifs. J Virol 77:9399–9411 [CrossRef]
    [Google Scholar]
  20. Lukac D. M., Renne R., Kirshner J. R., Ganem D. 1998; Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252:304–312 [CrossRef]
    [Google Scholar]
  21. Lukac D. M., Kirshner J. R., Ganem D. 1999; Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol 73:9348–9361
    [Google Scholar]
  22. Lukac D. M., Garibyan L., Kirshner J. R., Palmeri D., Ganem D. 2001; DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters. J Virol 75:6786–6799 [CrossRef]
    [Google Scholar]
  23. Miller G., Heston L., Grogan E., Gradoville L., Rigsby M., Sun R., Shedd D., Kushnaryov V. M., Grossberg S., Chang Y. 1997; Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein–Barr virus in dually infected body cavity lymphoma cells. J Virol 71:314–324
    [Google Scholar]
  24. Radkov S. A., Kellam P., Boshoff C. 2000; The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma–E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 6:1121–1127 [CrossRef]
    [Google Scholar]
  25. Rivas C., Thlick A. E., Parravicini C., Moore P. S., Chang Y. 2001; Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol 75:429–438 [CrossRef]
    [Google Scholar]
  26. Russo J. J., Bohenzky R. A., Chien M. C., Chen J., Yan M., Maddalena D., Parry J. P., Peruzzi D., Edelman I. S. other authors 1996; Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 93:14862–14867 [CrossRef]
    [Google Scholar]
  27. Sakakibara S., Ueda K., Chen J., Okuno T., Yamanishi K. 2001; Octamer-binding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression. J Virol 75:6894–6900 [CrossRef]
    [Google Scholar]
  28. Sharp T. V., Wang H. W., Koumi A., Hollyman D., Endo Y., Ye H., Du M. Q., Boshoff C. 2002; K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J Virol 76:802–816 [CrossRef]
    [Google Scholar]
  29. Song M. J., Li X., Brown H. J., Sun R. 2002; Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J Virol 76:5000–5013 [CrossRef]
    [Google Scholar]
  30. Song M. J., Deng H., Sun R. 2003; Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J Virol 77:9451–9462 [CrossRef]
    [Google Scholar]
  31. Staskus K. A., Zhong W., Gebhard K., Herndier B., Wang H., Renne R., Beneke J., Pudney J., Anderson D. J. other authors 1997; Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 71:715–719
    [Google Scholar]
  32. Sturzl M., Hohenadl C., Zietz C., Castanos-Velez E., Wunderlich A., Ascherl G., Biberfeld P., Monini P., Browning P. J., Ensoli B. 1999; Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J Natl Cancer Inst 91:1725–1733 [CrossRef]
    [Google Scholar]
  33. Sun R., Lin S. F., Gradoville L., Yuan Y., Zhu F., Miller G. 1998; A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 95:10866–10871 [CrossRef]
    [Google Scholar]
  34. Sun R., Lin S. F., Staskus K., Gradoville L., Grogan E., Haase A., Miller G. 1999; Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J Virol 73:2232–2242
    [Google Scholar]
  35. Wang S., Liu S., Wu M., Geng Y., Wood C. 2001a; Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 ORF50 gene product contains a potent C-terminal activation domain which activates gene expression via a specific target sequence. Arch Virol 146:1415–1426 [CrossRef]
    [Google Scholar]
  36. Wang S., Liu S., Wu M. H., Geng Y., Wood C. 2001b; Identification of a cellular protein that interacts and synergizes with the RTA (ORF50) protein of Kaposi's sarcoma-associated herpesvirus in transcriptional activation. J Virol 75:11961–11973 [CrossRef]
    [Google Scholar]
  37. Wang S. E., Wu F. Y., Fujimuro M., Zong J., Hayward S. D., Hayward G. S. 2003a; Role of CCAAT/enhancer-binding protein alpha (C/EBP α ) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP. J Virol 77:600–623 [CrossRef]
    [Google Scholar]
  38. Wang S. E., Wu F. Y., Yu Y., Hayward G. S. 2003b; CCAAT/enhancer-binding protein- α is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters. J Virol 77:9590–9612 [CrossRef]
    [Google Scholar]
  39. Wang J., Zhang J., Zhang L., Harrington W. Jr, West J. T., Wood C. 2005; Modulation of human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus replication and transcription activator transactivation by interferon regulatory factor 7. J Virol 79:2420–2431 [CrossRef]
    [Google Scholar]
  40. Xu Y., AuCoin D. P., Huete A. R., Cei S. A., Hanson L. J., Pari G. S. 2005; A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication. J Virol 79:3479–3487 [CrossRef]
    [Google Scholar]
  41. Yang Z., Wood C. 2007; The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus. J Virol 81:6294–6306 [CrossRef]
    [Google Scholar]
  42. Ziegelbauer J., Grundhoff A., Ganem D. 2006; Exploring the DNA binding interactions of the Kaposi's sarcoma-associated herpesvirus lytic switch protein by selective amplification of bound sequences in vitro. J Virol 80:2958–2967 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.2008.006817-0
Loading
/content/journal/jgv/10.1099/vir.2008.006817-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error